Literature DB >> 27567368

Structural determinants of diphenethylamines for interaction with the κ opioid receptor: Synthesis, pharmacology and molecular modeling studies.

Elena Guerrieri1, Marcel Bermudez2, Gerhard Wolber2, Ilona P Berzetei-Gurske3, Helmut Schmidhammer1, Mariana Spetea4.   

Abstract

The κ opioid (KOP) receptor crystal structure in an inactive state offers nowadays a valuable platform for inquiry into receptor function. We describe the synthesis, pharmacological evaluation and docking calculations of KOP receptor ligands from the class of diphenethylamines using an active-like structure of the KOP receptor attained by molecular dynamics simulations. The structure-activity relationships derived from computational studies was in accordance with pharmacological activities of targeted diphenethylamines at the KOP receptor established by competition binding and G protein activation in vitro assays. Our analysis identified that agonist binding results in breaking of the Arg156-Thr273 hydrogen bond, which stabilizes the inactive receptor conformation, and a crucial hydrogen bond with His291 is formed. Compounds with a phenolic 4-hydroxy group do not form the hydrogen bond with His291, an important residue for KOP affinity and agonist activity. The size of the N-substituent hosted by the hydrophobic pocket formed by Val108, Ile316 and Tyr320 considerably influences binding and selectivity, with the n-alkyl size limit being five carbon atoms, while bulky substituents turn KOP agonists in antagonists. Thus, combination of experimental and molecular modeling strategies provides an initial framework for understanding the structural features of diphenethylamines that are essential to promote binding affinity and selectivity for the KOP receptor, and may be involved in transduction of the ligand binding event into molecular changes, ultimately leading to receptor activation.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Agonist; Antagonist; Diphenethylamine; Molecular dynamics; Partial agonist; SAR; κ opioid receptor

Mesh:

Substances:

Year:  2016        PMID: 27567368     DOI: 10.1016/j.bmcl.2016.08.031

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  4 in total

1.  Selective κ receptor partial agonist HS666 produces potent antinociception without inducing aversion after i.c.v. administration in mice.

Authors:  Mariana Spetea; Shainnel O Eans; Michelle L Ganno; Aquilino Lantero; Michael Mairegger; Lawrence Toll; Helmut Schmidhammer; Jay P McLaughlin
Journal:  Br J Pharmacol       Date:  2017-06-27       Impact factor: 8.739

2.  Highly Potent and Selective New Diphenethylamines Interacting with the κ-Opioid Receptor: Synthesis, Pharmacology, and Structure-Activity Relationships.

Authors:  Filippo Erli; Elena Guerrieri; Tanila Ben Haddou; Aquilino Lantero; Michael Mairegger; Helmut Schmidhammer; Mariana Spetea
Journal:  J Med Chem       Date:  2017-08-30       Impact factor: 7.446

Review 3.  A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists.

Authors:  Kendall L Mores; Benjamin R Cummins; Robert J Cassell; Richard M van Rijn
Journal:  Front Pharmacol       Date:  2019-04-17       Impact factor: 5.810

Review 4.  Development of Diphenethylamines as Selective Kappa Opioid Receptor Ligands and Their Pharmacological Activities.

Authors:  Helmut Schmidhammer; Filippo Erli; Elena Guerrieri; Mariana Spetea
Journal:  Molecules       Date:  2020-11-02       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.